Clinical Evidence of Immune Tolerance Induction: Examples from Celiac Disease & Multiple Sclerosis

Time: 2:00 pm
day: Day 2 Treg Modulators Track PM

Details:

  • Exploring antigen targeting to effectively modulate a range of autoimmune diseases
  • Translating preclinical biology to clinical evidence: the role of regulatory T-cells in establishing immune tolerance
  • Unveiling clinical evidence of regulatory T-cell activity (including bystander/linked suppression)

Speakers: